Clinicopathological analysis of CD133 and NCAM human hepatic stem/progenitor cells in damaged livers and hepatocellular carcinomas [0.03%]
CD133和NCAM人肝干细胞/前体细胞的临床病理分析及其在肝脏损伤和肝细胞癌中的作用
Atsunori Tsuchiya,Hiroteru Kamimura,Masaaki Takamura et al.
Atsunori Tsuchiya et al.
Aim: Hepatic stem cells are capable of dramatically changing and differentiating to form mature hepatocytes in acute and chronically damaged livers; however, the clinicopathological characteristics of these heterogeneous ...
New scoring system for predicting relapse after lamivudine-induced hepatitis B e-antigen loss in chronic hepatitis B patients [0.03%]
替比夫定治疗后乙肝e抗原血清学转换患者停药后的复发风险预测模型
Byung-Cheol Song,Xiu Ji Cui,Yoo-Kyung Cho et al.
Byung-Cheol Song et al.
Aim: In endemic areas of hepatitis B virus (HBV) infection, lamivudine-induced hepatitis B e-antigen (HBeAg) loss is not durable. We developed a scoring system to predict the relapse after lamivudine-induced HBeAg loss. ...